BMED Top Holdings & Constituents
BMED, offered by BlackRock, holds 52 reported positions across $11.2M in assets. Its largest holdings are Johnson & Johnson (JNJ) (7.88%), Gilead Sciences Inc (GILD) (5.40%), and Edwards Lifesciences Corp (EW) (4.74%). The 5 biggest positions account for 26.97% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
JNJ Johnson & Johnson | 7.88% | $795.05K |
GILD Gilead Sciences Inc | 5.40% | $544.95K |
EW Edwards Lifesciences Corp | 4.74% | $478.12K |
AMGN Amgen Inc | 4.60% | $464.67K |
— BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES | 4.36% | $440.00K |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Apr 30, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.